Search

Your search keyword '"Deek, Matthew P."' showing total 232 results
Start Over Author "Deek, Matthew P."
232 results on '"Deek, Matthew P."'

1. Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer

Author

Wang, Jarey H., Deek, Matthew P., Mendes, Adrianna A., Song, Yang, Shetty, Amol, Bazyar, Soha, Van der Eecken, Kim, Chen, Emmalyn, Showalter, Timothy N., Royce, Trevor J., Todorovic, Tamara, Huang, Huei-Chung, Houck, Scott A., Yamashita, Rikiya, Kiess, Ana P., Song, Daniel Y., Lotan, Tamara, DeWeese, Theodore, Marchionni, Luigi, Ren, Lei, Sawant, Amit, Simone, Nicole, Berlin, Alejandro, Onal, Cem, Esteva, Andre, Feng, Felix Y., Tran, Phuoc T., Sutera, Philip, and Ost, Piet

Published
2025
Full Text
View/download PDF

2. Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer

Author

Sutera, Philip, Deek, Matthew P., Deek, Rebecca A., Guler, Ozan Cem, Hurmuz, Pervin, Reyhan, Mehmet, Rowe, Steven, Radwan, Noura, Dipasquale, Shirl, Hrinivich, William T., Lowe, Kathryn, Ren, Lei, Saraiya, Biren, Ennis, Ronald, Hathout, Lara, Mayer, Tina, Deweese, Theodore L., Song, Daniel Y., Kiess, Ana, Oymak, Ezgi, Pienta, Kenneth, Feng, Felix, Pomper, Martin, Ozyigit, Gokhan, Tran, Phuoc T., Onal, Cem, and Phillips, Ryan M.

Published
2024
Full Text
View/download PDF

4. The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

Author

Deek, Matthew P, Van der Eecken, Kim, Phillips, Ryan, Parikh, Neil R, Velho, Pedro Isaacsson, Lotan, Tamara L, Kishan, Amar U, Maurer, Tobias, Consortium, GAP6, Boutros, Paul C, Hovens, Christopher, Abramowtiz, Matthew, Pollack, Alan, Desai, Neil, Stish, Bradley, Feng, Felix Y, Eisenberger, Mario, Carducci, Michael, Pienta, Kenneth J, Markowski, Mark, Paller, Channing J, Antonarakis, Emmanuel S, Berlin, Alejandro, Ost, Piet, and Tran, Phuoc T

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Urologic Diseases, Genetics, Prostate Cancer, Aging, Cancer, High-Throughput Nucleotide Sequencing, Humans, Male, Mutation, Neoplasm Metastasis, Neoplasm Recurrence, Local, Prostatic Neoplasms, Castration-Resistant, Retrospective Studies, Treatment Outcome, Oligometastatic prostate cancer, Next Generation Sequencing, GAP6 Consortium, Urology & Nephrology, Clinical sciences
Abstract

BackgroundEmerging data suggest that metastasis is a spectrum of disease burden rather than a binary state, and local therapies, such as radiation, might improve outcomes in oligometastasis. However, current definitions of oligometastasis are solely numerical.ObjectiveTo characterize the somatic mutational landscape across the disease spectrum of metastatic castration-sensitive prostate cancer (mCSPC) to elucidate a biological definition of oligometastatic CSPC.Design, setting, and participantsThis was a retrospective study of men with mCSPC who underwent clinical-grade sequencing of their tumors (269 primary tumor, 25 metastatic sites). Patients were classified as having biochemically recurrent (ie, micrometastatic), metachronous oligometastatic (≤5 lesions), metachronous polymetastatic (>5 lesions), or de novo metastatic (metastasis at diagnosis) disease.Outcome measurements and statistical analysisWe measured the frequency of driver mutations across metastatic classifications and the genomic associations with radiographic progression-free survival (rPFS) and time to castrate-resistant prostate cancer (CRPC).Results and limitationsThe frequency of driver mutations in TP53 (p =  0.01), WNT (p =  0.08), and cell cycle (p =  0.04) genes increased across the mCSPC spectrum. TP53 mutation was associated with shorter rPFS (26.7 vs 48.6 mo; p =  0.002), and time to CRPC (95.6 vs 155.8 mo; p =  0.02) in men with oligometastasis, and identified men with polymetastasis with better rPFS (TP53 wild-type, 42.7 mo; TP53 mutated, 18.5 mo; p =  0.01). Mutations in TP53 (incidence rate ratio [IRR] 1.45; p =  0.004) and DNA double-strand break repair (IRR 1.61; p

Published
2021

5. Can Sex and Seniority Predict the Quality of a Journal Reviewers Manuscript Critique?

Author

Jamorabo, Daniel, Deek, Matthew, Yom, Sue, Rehman, Hasan, Zietman, Anthony, Motwani, Sabin, Briggs, William, Kim, Sinae, Chang, Daniel, and Jabbour, Salma

Subjects
Female, Humans, Male, Peer Review, Research, Publishing, Radiation Oncology
Abstract

PURPOSE: To evaluate reviewers timeliness and review quality for the International Journal of Radiation Oncology, Biology, Physics (IJROBP) by sex and seniority. METHODS AND MATERIALS: The IJROBP editorial office provided data on 3962 individuals invited to review manuscripts from 2011 through 2014. We identified 1657 reviewers who had been invited to provide a review on at least 3 occasions during the study period and compared review timeliness and scoring between male and female reviewers. We confirmed the reviewers sex after having unblinded their names based on our personal acquaintance with them and via an Internet search on their department websites. We then did a subset analysis of 124 US-based reviewers who had returned a major revision decision. We used the Review Quality Instrument (RQI) to rate their reviews. We used odds ratios and t tests to look for differences in mean RQI scores and factors that might be associated with quality-in particular, Hirsch indices (h indices) and year of first certification. RESULTS: Of the 1657 reviewers of interest, 1245 (75.1%) were men and 412 (24.9%) were women. We found no statistically significant differences between men and women in the time to respond to invitations. There were no statistically significant differences in timeliness or review reminders based on sex. Our subset analysis showed no difference in quality (RQI scores) based on the reviewers sex, h index, or year of first certification. CONCLUSIONS: Women and men render reviews of equal quality regardless of seniority and h index, yet women have been invited less frequently to review. This is likely because of the underrepresentation of women in radiation oncology. A more balanced academic population is needed to address this continuing disparity of womens representation in academic publishing.

Published
2021

6. Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer

Author

Deek, Matthew P., Sutera, Philip, Jing, Yuezhou, Gao, Robert, Rothman, Emily, Day, Heather, Chang, David, Dirix, Piet, Armstrong, Andrew J., Campbell, Bethany, Lopez Campos, Fernando, Berenguer, Miguel, Ramotar, Matthew, Conde-Moreno, Antonio, Berlin, Alejandro, Bosetti, Davide Giovanni, Corcoran, Niall, Koontz, Bridget, Mercier, Carole, Siva, Shankar, Pryor, David, Ost, Piet, Huynh, Mai Anh, Kroeze, Stephanie, Stish, Bradley, Kiess, Ana, Trock, Bruce, Tran, Phuoc T., Gillessen, Silke, and Sweeney, Christopher

Published
2024
Full Text
View/download PDF

10. Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer

Author

Kishan, Amar U, Romero, Tahmineh, Alshalalfa, Mohammed, Liu, Yang, Tran, Phuoc T, Nickols, Nicholas G, Ye, Huihui, Sajed, Dipti, Rettig, Matthew B, Reiter, Robert E, Garraway, Isla P, Spratt, Daniel E, Freedland, Steven J, Zhao, Xin, Li, Ziwen, Deek, Matthew, Livingstone, Julie, Mahal, Brandon A, Nguyen, Paul L, Feng, Felix Y, Den, Robert B, Schaeffer, Edward M, Lotan, Tamara L, Karnes, R Jeffrey, Klein, Eric A, Ross, Ashley E, Grogan, Tristan, Davicioni, Elai, Elashoff, David, Boutros, Paul C, and Weidhaas, Joanne B

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Cancer, Prostate Cancer, Aging, Biotechnology, Clinical Trials and Supportive Activities, Genetics, Human Genome, Clinical Research, Urologic Diseases, Aetiology, 2.1 Biological and endogenous factors, Aged, Cohort Studies, Genetic Variation, Humans, Male, Middle Aged, Neoplasm Grading, Prostatic Neoplasms, Transcriptome, Gleason grade group 5, Gleason score 9, Gleason score 10, Biomarkers, Transcriptomics, Urology & Nephrology, Clinical sciences
Abstract

Gleason grade group (GG) 5 prostate cancer has been associated with an aggressive natural history, and retrospective data support a role for treatment intensification. However, clinical outcomes remain heterogeneous in this cohort, and intensified treatments carry an increased risk of adverse events. We sought to explore the transcriptomic heterogeneity of GG 5 tumors by querying transcriptomic data from the tumors of 2138 patients with GG 5 disease who underwent prostatectomy. Four distinct consensus clusters were identified with respect to differential transcriptional activation of hallmark pathways, with distinct molecular subtyping profiles and different average genomic risks (AGRs). One cluster, accounting for 325 tumors (15.2% of the population), was enriched for genes related to the cell cycle/proliferation, metabolic pathways, androgen response pathways, and DNA repair, and had a higher AGR than the other clusters (p

Published
2020

11. WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer

Author

Sutera, Philip, Deek, Matthew P., Van der Eecken, Kim, Shetty, Amol C., Chang, Jin Hee, Hodges, Theresa, Song, Yang, Verbeke, Sofie, Van Dorpe, Jo, Fonteyne, Valérie, De Laere, Bram, Mishra, Mark, Rana, Zaker, Molitoris, Jason, Ferris, Matthew, Ross, Ashley, Schaeffer, Edward, Roberts, Nicholas, Song, Daniel Y., DeWeese, Theodore, Pienta, Kenneth J., Antonarakis, Emmanuel S., Ost, Piet, and Tran, Phuoc T.

Published
2023
Full Text
View/download PDF

12. Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer

Author

Yegya-Raman, Nikhil, Kegelman, Timothy P., Ho Lee, Sang, Kallan, Michael J., Kim, Kristine N., Natarajan, Jyotsna, Deek, Matthew P., Zou, Wei, O'Reilly, Shannon E., Zhang, Zheng, Levin, William, Cengel, Keith, Kao, Gary, Cohen, Roger B., Sun, Lova L., Langer, Corey J., Aggarwal, Charu, Singh, Aditi P., O'Quinn, Rupal, Ky, Bonnie, Apte, Aditya, Deasy, Joseph, Xiao, Ying, Berman, Abigail T., Jabbour, Salma K., and Feigenberg, Steven J.

Published
2023
Full Text
View/download PDF

13. Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics

Author

Sutera, Philip, Van Der Eecken, Kim, Kishan, Amar U., Hamid, Anis, Grist, Emily, Attard, Gerhardt, Lotan, Tamara, Mendes, Adrianna A., Paller, Channing J., Carducci, Michael A., Ross, Ashley, Wang, Hao, Pienta, Ken, Feng, Felix Y., Antonarakis, Emmanuel S., Ost, Piet, Song, Daniel Y., Greco, Stephen, Deville, Curtiland, DeWeese, Theodore, Tran, Phuoc T., and Deek, Matthew P.

Published
2022
Full Text
View/download PDF

16. Evaluation of Treatment Outcomes of Prostate Cancer Patients With Lymph Node Metastasis Treated With Definitive Radiotherapy

Author

Onal, Cem, primary, Guler, Ozan Cem, additional, Erpolat, Petek, additional, Hurmuz, Pervin, additional, Sutera, Philip, additional, Deek, Matthew P., additional, Elmali, Aysenur, additional, Yilmaz, Melek Tugce, additional, Koken, Ummu Habibe, additional, Yavuz, Melek, additional, Ozyigit, Gokhan, additional, and Tran, Phuoc T., additional

Published
2024
Full Text
View/download PDF

17. Prostate-specific membrane antigen PET response associates with metastasis-free survival following stereotactic ablative radiation in oligometastatic prostate cancer

Author

Sutera, Philip, primary, Deek, Matthew P., additional, Deek, Rebecca A., additional, Guler, Ozan Cem, additional, Hurmuz, Pervin, additional, Reyhan, Mehmet, additional, Rowe, Steven, additional, Radwan, Noura, additional, Dipasquale, Shirl, additional, Hrinivich, William T., additional, Lowe, Kathryn, additional, Ren, Lei, additional, Saraiya, Biren, additional, Ennis, Ronald, additional, Hathout, Lara, additional, Mayer, Tina, additional, Deweese, Theodore L., additional, Song, Daniel Y., additional, Kiess, Ana, additional, Oymak, Ezgi, additional, Pienta, Kenneth, additional, Feng, Felix, additional, Pomper, Martin, additional, Ozyigit, Gokhan, additional, Tran, Phuoc T., additional, Onal, Cem, additional, and Phillips, Ryan M., additional

Published
2024
Full Text
View/download PDF

19. Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer

Author

Deek, Matthew P., Taparra, Kekoa, Phillips, Ryan, Velho, Pedro Isaacsson, Gao, Robert W., Deville, Curtiland, Song, Daniel Y., Greco, Stephen, Carducci, Michael, Eisenberger, Mario, DeWeese, Theodore L., Denmeade, Samuel, Pienta, Kenneth, Paller, Channing J., Antonarakis, Emmanuel S., Olivier, Kenneth R., Park, Sean S., Tran, Phuoc T., and Stish, Bradley J.

Published
2021
Full Text
View/download PDF

20. Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712

Author

Rana, Zaker, Kamran, Sophia C., Shetty, Amol C., Sutera, Philip, Song, Yang, Bazyar, Soha, Solanki, Abhishek A., Simko, Jeffry P., Pollack, Alan, McConkey, David, Kates, Max, Siddiqui, M. Minhaj, Hiken, Jeffrey, Earls, Jon, Messina, David, Mouw, Kent W., Miyamoto, David, Shipley, William U., Michaelson, M. Dror, Zietman, Anthony, Coen, John J., Dahl, Douglas M., Jani, Ashesh B., Souhami, Luis, Chang, Brian K., Lee, R. Jeffrey, Pham, Huong, Marshall, David T., Shen, Xinglei, Pugh, Stephanie L., Feng, Felix Y., Efstathiou, Jason A., Tran, Phuoc T., and Deek, Matthew P.

Abstract

A novel transcriptional profiling platform revealed that gene expression consistent with high immune-cell infiltration and of specific genes associated with T-cell infiltration or IFNγ signaling was correlated with better survival following chemoradiation for muscle-invasive bladder cancer.

Published
2024
Full Text
View/download PDF

21. Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer

Author

Deek, Matthew P., Taparra, Kekoa, Dao, Dyda, Chan, Luanna, Phillips, Ryan, Gao, Robert W., Kwon, Eugene D., Deville, Curtiland, Song, Daniel Y., Greco, Stephen, Carducci, Michael A., Eisenberger, Mario, DeWeese, Theodore L., Denmeade, Samuel, Pienta, Kenneth, Paller, Channing J., Antonarakis, Emmanuel S., Olivier, Kenneth R., Park, Sean S., Stish, Bradley J., and Tran, Phuoc T.

Published
2021
Full Text
View/download PDF

27. Validation of a digital pathology-based multimodal artificial intelligence model in oligometastatic castration-sensitive prostate cancer, including in patients from the STOMP and ORIOLE phase II randomized clinical trials.

Author

Sutera, Philip Anthony, Deek, Matthew Pierre, Mendes, Adrianna, Song, Yang, Shetty, Amol, Van der Eecken, Kim, Chen, Emmalyn, Showalter, Timothy N, Royce, Trevor Joseph, Todorovic, Tamara, Huang, Huei-Chung, Houck, Scott, Yamashita, Rikiya, Kiess, Ana Ponce, Song, Daniel, Lotan, Tamara L., Esteva, Andre, Feng, Felix Y, Tran, Phuoc T., and Ost, Piet

Published
2024
Full Text
View/download PDF

28. TP53 structure–function relationships in metastatic castrate‐sensitive prostate cancer and the impact of APR‐246 treatment

Author

Hoang, Tung, primary, Sutera, Philip, additional, Nguyen, Triet, additional, Chang, Jinhee, additional, Jagtap, Shreya, additional, Song, Yang, additional, Shetty, Amol C., additional, Chowdhury, Dipanwita D., additional, Chan, Aaron, additional, Carrieri, Francesca A., additional, Hathout, Lara, additional, Ennis, Ronald, additional, Jabbour, Salma K., additional, Parikh, Rahul, additional, Molitoris, Jason, additional, Song, Daniel Y., additional, DeWeese, Theodore, additional, Marchionni, Luigi, additional, Ren, Lei, additional, Sawant, Amit, additional, Simone, Nicole, additional, Lafargue, Audrey, additional, Van Der Eecken, Kim, additional, Bunz, Fred, additional, Ost, Piet, additional, Tran, Phuoc T., additional, and Deek, Matthew P., additional

Published
2023
Full Text
View/download PDF

31. Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment

Author

Moyer, C. Leigh, Phillips, Ryan, Deek, Matthew P., Radwan, Noura, Ross, Ashley E., Antonarakis, Emmanuel S., Reyes, Diane, Wright, Jean, Terezakis, Stephanie A., Song, Daniel Y., DeVille, Curtiland, Walsh, Patrick C., DeWeese, Theodore L., Carducci, Michael, Schaeffer, Edward M., Pienta, Kenneth J., Eisenberger, Mario, and Tran, Phuoc T.

Published
2019
Full Text
View/download PDF

33. Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research

Author

Kumar, Ritesh, primary, Kim, Jongmyung, additional, Deek, Matthew P., additional, Eskander, Mariam F., additional, Gulhati, Prateek, additional, In, Haejin, additional, Kennedy, Timothy, additional, Shah, Mihir M., additional, Grandhi, Miral S., additional, Berim, Lyudmyla, additional, Spencer, Kristen R., additional, Langan, Russell C., additional, Hochster, Howard S., additional, Boland, Patrick M., additional, and Jabbour, Salma K., additional

Published
2023
Full Text
View/download PDF

34. A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

Author

Hasan, Hamza, Deek, Matthew P., Phillips, Ryan, Hobbs, Robert F., Malek, Reem, Radwan, Noura, Kiess, Ana P., Dipasquale, Shirl, Huang, James, Caldwell, Terry, Leitzel, Jessica, Wendler, Danielle, Wang, Hao, Thompson, Elizabeth, Powell, Jonathan, Dudley, Sara, Deville, Curtiland, Greco, Stephen C., Song, Daniel Y., DeWeese, Theodore L., Gorin, Michael A., Rowe, Steven P., Denmeade, Sam, Markowski, Mark, Antonarakis, Emmanuel S., Carducci, Michael A., Eisenberger, Mario A., Pomper, Martin G., Pienta, Kenneth J., Paller, Channing J., and Tran, Phuoc T.

Published
2020
Full Text
View/download PDF

37. Metastasis-Directed Therapy In Prostate Cancer: Why, When, and How?

Author

Phillips, Ryan M., Deek, Matthew P., DeWeese, Theodore L., and Tran, Phuoc T.

Subjects
Prostate cancer -- Development and progression, Ipilimumab -- Health aspects, Metastasis -- Development and progression, Radiation -- Health aspects, Pain -- Care and treatment, Radiotherapy -- Health aspects, Health
Abstract

Metastatic prostate cancer remains a life-limiting disease; while we have seen significant advances in systemic approaches which form the backbone of management, no curative paradigm yet exists. Metastasis-directed therapy (MDT) with stereotactic ablative radiotherapy (SABR) has emerged as a promising complementary technique for the management of low-volume metastatic prostate cancer. Herein we will review the rationale, potential benefits, and practical considerations associated with this approach., Why Treat Prostate Cancer Metastases with Ablative Radiation? Rationale for Metastasis-Directed Therapy (MDT) in Prostate Cancer Traditionally, the management of metastatic cancer has been chiefly through systemic treatments (excellent summary [...]

Published
2019

38. Locally Advanced Lung Cancer

Author

Oh, Sarah, primary, Botros, George N., additional, Patel, Milan, additional, Haigentz, Missak, additional, Patel, Eshan, additional, Kontopidis, Iaonnis, additional, Langenfeld, John, additional, Deek, Matthew P., additional, and Jabbour, Salma K., additional

Published
2023
Full Text
View/download PDF

40. A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

Author

Kapoor, Roche, Deek, Matthew P., McIntyre, Riley, Raman, Natasha, Kummerlowe, Megan, Chen, Iyah, Gaver, Matt, Wang, Hao, Denmeade, Sam, Lotan, Tamara, Paller, Channing, Markowski, Mark, Carducci, Michael, Eisenberger, Mario, Beer, Tomasz M., Song, Daniel Y., DeWeese, Theodore L., Hearn, Jason W., Greco, Stephen, DeVille, Curtiland, Desai, Neil B., Heath, Elisabeth I., Liauw, Stanley, Spratt, Daniel E., Hung, Arthur Y., Antonarakis, Emmanuel S., and Tran, Phuoc T.

Published
2019
Full Text
View/download PDF

43. Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial

Author

Tran, Phuoc T., primary, Lowe, Kathryn, additional, Tsai, Hua-Ling, additional, Song, Daniel Y., additional, Hung, Arthur Y., additional, Hearn, Jason W.D., additional, Miller, Steven, additional, Proudfoot, James A., additional, Deek, Matthew P., additional, Phillips, Ryan, additional, Lotan, Tamara, additional, Paller, Channing J., additional, Marshall, Catherine H., additional, Markowski, Mark, additional, Dipasquale, Shirl, additional, Denmeade, Samuel, additional, Carducci, Michael, additional, Eisenberger, Mario, additional, DeWeese, Theodore L., additional, Orton, Matthew, additional, Deville, Curtiland, additional, Davicioni, Elai, additional, Liauw, Stanley L., additional, Heath, Elisabeth I., additional, Greco, Stephen, additional, Desai, Neil B., additional, Spratt, Daniel E., additional, Feng, Felix, additional, Wang, Hao, additional, Beer, Tomasz M., additional, and Antonarakis, Emmanuel S., additional

Published
2023
Full Text
View/download PDF

47. Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

Author

Deek, Matthew P., primary, Van der Eecken, Kim, additional, Sutera, Philip, additional, Deek, Rebecca A., additional, Fonteyne, Valérie, additional, Mendes, Adrianna A., additional, Decaestecker, Karel, additional, Kiess, Ana Ponce, additional, Lumen, Nicolaas, additional, Phillips, Ryan, additional, De Bruycker, Aurélie, additional, Mishra, Mark, additional, Rana, Zaker, additional, Molitoris, Jason, additional, Lambert, Bieke, additional, Delrue, Louke, additional, Wang, Hailun, additional, Lowe, Kathryn, additional, Verbeke, Sofie, additional, Van Dorpe, Jo, additional, Bultijnck, Renée, additional, Villeirs, Geert, additional, De Man, Kathia, additional, Ameye, Filip, additional, Song, Daniel Y., additional, DeWeese, Theodore, additional, Paller, Channing J., additional, Feng, Felix Y., additional, Wyatt, Alexander, additional, Pienta, Kenneth J., additional, Diehn, Maximillian, additional, Bentzen, Soren M., additional, Joniau, Steven, additional, Vanhaverbeke, Friedl, additional, De Meerleer, Gert, additional, Antonarakis, Emmanuel S., additional, Lotan, Tamara L., additional, Berlin, Alejandro, additional, Siva, Shankar, additional, Ost, Piet, additional, and Tran, Phuoc T., additional

Published
2022
Full Text
View/download PDF

50. Genomic biomarkers to guide precision radiotherapy in prostate cancer

Author

Sutera, Philip, primary, Deek, Matthew P., additional, Van der Eecken, Kim, additional, Wyatt, Alexander W., additional, Kishan, Amar U., additional, Molitoris, Jason K., additional, Ferris, Matthew J., additional, Siddiqui, M. Minhaj, additional, Rana, Zaker, additional, Mishra, Mark V., additional, Kwok, Young, additional, Davicioni, Elai, additional, Spratt, Daniel E., additional, Ost, Piet, additional, Feng, Felix Y., additional, and Tran, Phuoc T., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results